Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
Sang Chul Lee, Kee-Hwan Kim, Ok-Hee Kim, Sang Kuon Lee, Ha-Eun Hong, Byung Jo Choi, Wonjun Jeong, Say-June Kim
Cancer Res Treat. 2018;50(3):1023-1038.   Published online 2017 Nov 9     DOI: https://doi.org/10.4143/crt.2017.085
Citations to this article as recorded by Crossref logo
Combining Everolimus and Ku0063794 Promotes Apoptosis of Hepatocellular Carcinoma Cells via Reduced Autophagy Resulting from Diminished Expression of miR-4790-3p
Ho Choi, Jung Park, Ok-Hee Kim, Kee-Hwan Kim, Ha Hong, Haeyeon Seo, Say-June Kim
International Journal of Molecular Sciences.2021; 22(6): 2859.     CrossRef
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
Marius Farcas, Andrei-Alexandru Gavrea, Diana Gulei, Calin Ionescu, Alexandru Irimie, Cristina S. Catana, Ioana Berindan-Neagoe
Frontiers in Nutrition.2019;[Epub]     CrossRef
A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis
Andreas Kroh, Jeanette Walter, Herdit Schüler, Jochen Nolting, Roman Eickhoff, Daniel Heise, Ulf Peter Neumann, Thorsten Cramer, Tom Florian Ulmer, Athanassios Fragoulis
International Journal of Molecular Sciences.2019; 20(22): 5658.     CrossRef
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
Na Kong, Wei Tao, Xiang Ling, Junqing Wang, Yuling Xiao, Sanjun Shi, Xiaoyuan Ji, Aram Shajii, Silvia Tian Gan, Na Yoon Kim, Dan G. Duda, Tian Xie, Omid C. Farokhzad, Jinjun Shi
Science Translational Medicine.2019; 11(523): eaaw1565.     CrossRef